Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.1100
+0.1089 (9,900.00%)
Mar 24, 2026, 9:57 AM EST
Sofgen Pharma Revenue
In the year 2024, Sofgen Pharma had annual revenue of $373.80M, down -11.79%. Sofgen Pharma had revenue of $118.41M in the quarter ending September 30, 2023, with 7.25% growth.
Revenue
373.80M
Revenue Growth
-8.48%
P/S Ratio
0.68
Revenue / Employee
83.10K
Employees
5,000
Market Cap
256.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 373.80M | -49.95M | -11.79% |
| Dec 31, 2023 | 423.75M | 20.55M | 5.10% |
| Dec 31, 2022 | 403.20M | -536.00K | -0.13% |
| Jan 1, 2022 | 403.74M | 72.27M | 21.80% |
| Dec 31, 2020 | 331.47M | 6.68M | 2.06% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medical Marijuana | 58.98M |
| CordovaCann | 10.25M |
| Panacea Life Sciences Holdings | 2.76M |
| CannaPharmaRX | 1.71M |
| Bespoke Extracts | 1.42M |
| SOHM, Inc. | 1.30M |
| Redwood Scientific Technologies | 259.71K |
| Full Alliance Group | 82.12K |